ArticleRadiation oncology (London, England)2022

Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study.

Li Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.